Suppr超能文献

尼泊尔加德满都谷地注射毒品女性中艾滋病毒、丙型肝炎及其相关风险行为的流行情况:一项横断面研究。

Prevalence of HIV, Hepatitis C and its related risk behaviours among women who inject drugs in the Kathmandu Valley, Nepal: a cross-sectional study.

作者信息

Damas José, Storm Margrethe, Pandey Lok Raj, Marrone Gaetano, Deuba Keshab

机构信息

Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.

National Centre for AIDS and STD Control, Ministry of Health and Population, Kathmandu, Nepal.

出版信息

Ther Adv Infect Dis. 2021 Dec 3;8:20499361211062107. doi: 10.1177/20499361211062107. eCollection 2021 Jan-Dec.

Abstract

BACKGROUND

People who inject drugs (PWID) are at great risk of HIV and Hepatitis C Virus (HCV). In order to properly design interventions and develop programmes for women who inject drugs, this study assessed the prevalence of HIV, Hepatitis B, Hepatitis C, and syphilis and its risk behaviours among women who inject drugs in the Kathmandu Valley, Nepal.

METHODS

Through modified network sampling in three districts in the Kathmandu Valley, Nepal, this cross-sectional study enrolled a total of 160 women who inject drugs. Participants' serum samples were tested for HIV, HCV, Hepatitis B virus (HBV) and syphilis and risk behaviours were assessed through a structured questionnaire. Primary outcome variables were HIV, HCV, HBV and syphilis prevalence, and secondary outcome variables were sharing needles in the past month and using condom in last sexual intercourse. Stepwise logistic regression was used to determine micro- and macroenvironmental factors associated with secondary outcomes.

RESULTS

The prevalence of HIV, HCV, and HBV was 8.8%, 21.3%, and 1.9%, respectively. HIV-HCV co-infection rate was 5.6%. Fifteen percent of women who inject drugs reported transactional sex for drugs or money. One in four women who inject drugs (27.5%) reported that they were imprisoned or detained for drug related reasons. In multivariable analysis, women living with HIV who inject drugs were almost four times more likely to use a previously used needle/syringe than women who inject drugs who were HIV negative (aOR: 4.2 CI: 1.1-15.9,  = 0.03), but were almost four times more likely to use a condom during sexual intercourse (aOR: 3.5 CI: 1.1-28.9,  = 0.03). Enrolment in family planning was the main determinant for using condoms in last sexual intercourse (aOR 4.9 CI: 1.6-16.7,  = 0.006). Participants with access to HIV test and counselling (HTC) services were less likely to share needles (aOR: 0.3, 95% CI: 0.1-0.8,  = 0.01).

CONCLUSION

Prevalence of HIV and HCV is high among women who inject drugs in Kathmandu valley of Nepal. Women who inject drugs enrolled in national programmes such as family planning and HTC were positively associated with condom use, and less likely to share needles.

摘要

背景

注射毒品者面临感染艾滋病毒和丙型肝炎病毒(HCV)的巨大风险。为了妥善设计针对注射毒品女性的干预措施并制定相关项目,本研究评估了尼泊尔加德满都谷地注射毒品女性中艾滋病毒、乙型肝炎、丙型肝炎和梅毒的流行情况及其风险行为。

方法

通过对尼泊尔加德满都谷地三个区进行改良网络抽样,这项横断面研究共纳入了160名注射毒品女性。对参与者的血清样本进行艾滋病毒、丙型肝炎病毒、乙型肝炎病毒(HBV)和梅毒检测,并通过结构化问卷评估风险行为。主要结局变量为艾滋病毒、丙型肝炎病毒、乙型肝炎病毒和梅毒的流行率,次要结局变量为过去一个月共用针头情况以及最近一次性交时使用避孕套情况。采用逐步逻辑回归来确定与次要结局相关的微观和宏观环境因素。

结果

艾滋病毒、丙型肝炎病毒和乙型肝炎病毒的流行率分别为8.8%、21.3%和1.9%。艾滋病毒 - 丙型肝炎病毒合并感染率为5.6%。15%的注射毒品女性报告有以毒品或金钱交易性行为的情况。四分之一的注射毒品女性(27.5%)报告曾因与毒品相关的原因被监禁或拘留。在多变量分析中,感染艾滋病毒的注射毒品女性使用过的针头/注射器的可能性几乎是未感染艾滋病毒的注射毒品女性的四倍(调整后比值比:4.2,置信区间:1.1 - 15.9,P = 0.03),但在性交时使用避孕套的可能性几乎也是四倍(调整后比值比:3.5,置信区间:1.1 - 28.9,P = 0.03)。参与计划生育是最近一次性交时使用避孕套的主要决定因素(调整后比值比4.9,置信区间:1.6 - 16.7,P = 0.006)。能够获得艾滋病毒检测与咨询(HTC)服务的参与者共用针头的可能性较小(调整后比值比:0.3,95%置信区间:0.1 - 0.8,P = 0.01)。

结论

在尼泊尔加德满都谷地注射毒品的女性中,艾滋病毒和丙型肝炎病毒的流行率较高。参与计划生育和艾滋病毒检测与咨询等国家项目的注射毒品女性与使用避孕套呈正相关,且共用针头的可能性较小。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea8f/8646840/f48e2bfd3d5f/10.1177_20499361211062107-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验